Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction
Regenerative Biomaterials · 02.01.2024 · 11
DOI: 10.1093/rb/rbad108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 13.12.2023. Verfasst von Ming Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Suzhou Medical College, Soochow Univers…. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Cardiovascular Medicine Innovation Center, Scientific Research Project of Jiangsu Commission of Health.
Abstract (Originalsprache)
Nanoparticle-mediated drug delivery has emerged as a highly promising and effective therapeutic approach for addressing myocardial infarction. However, clinical translation tends to be a failure due to low cardiac retention as well as liver and spleen entrapment in previous therapies. Herein, we report a two-step exosome delivery system, which precludes internalization by the mononuclear phagocyte system before the delivery of therapeutic cardiac targeting exosomes (ExoCTP). Importantly, curcumin released by ExoCTP diminishes reactive oxygen species over-accumulation in ischemic myocardium, as well as serum levels of lactate dehydrogenase, malonyldialdehyde, superoxide dismutase and glutathione, indicating better antioxidant capacity than free curcumin. Finally, our strategy was proven to greatly potentiate the delivery and therapeutic efficacy of curcumin without systemic toxicity. Taken together, our smart exosome-mediated drug delivery strategy can serve either as therapeutics alone or in combination with other drugs for effective heart targeting and subsequent wound healing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Suzhou Medical College, Soochow University, Suzhou 215006, China.
ORCID-Profile: Weiqian Chen
Förderung
- National Natural Science Foundation of China
- Jiangsu Cardiovascular Medicine Innovation Center
- Scientific Research Project of Jiangsu Commission of Health
Zitieren
APA
Chen, M., Wang, S., Chen, Y., Shen, H., Chen, L., Ding, L., Tang, Q., Yang, Z., Chen, W., & Shen, Z. (2024). Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction. Regenerative Biomaterials, 11. https://doi.org/10.1093/rb/rbad108
Vancouver
Chen M, Wang S, Chen Y, Shen H, Chen L, Ding L, et al. Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction. Regenerative Biomaterials. 2024;11. doi:10.1093/rb/rbad108
BibTeX
@article{Chen2024,
author = {Chen, Ming and Wang, Shengnan and Chen, Yihuan and Shen, Han and Chen, Lei and Ding, Liang and Tang, Qingsong and Yang, Ziying and Chen, Weiqian and Shen, Zhenya},
title = {Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction},
journal = {Regenerative Biomaterials},
year = {2024},
volume = {11},
doi = {10.1093/rb/rbad108}
}
EUVIMED